Profound Medical (PROF) Enterprise Value Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Profound Medical | 244.28 Mn | 193.99 Mn | 3.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.32% |
| Dec 31, 2025 | -8.76% |
| Sep 30, 2025 | 5.29% |
| Jun 30, 2025 | 24.34% |
| Mar 31, 2025 | -12.76% |
| Dec 31, 2024 | -109.48% |
| Sep 30, 2024 | 22.04% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 11.47% |
| Dec 31, 2023 | 43.65% |
| Sep 30, 2023 | 49.94% |
| Jun 30, 2023 | 30.73% |
| Mar 31, 2023 | 30.73% |
| Dec 31, 2022 | 30.89% |
| Sep 30, 2022 | 7.00% |
| Jun 30, 2022 | 19.97% |
| Mar 31, 2022 | 19.97% |
| Dec 31, 2021 | -104,478.73% |
| Sep 30, 2021 | 12.83% |
| Jun 30, 2021 | -505.30% |
| Mar 31, 2021 | -81.74% |
| Dec 31, 2020 | 99.56% |
| Sep 30, 2020 | -204.28% |
| Jun 30, 2020 | 39.56% |
| Mar 31, 2020 | -100.09% |
| Dec 31, 2019 | 37.37% |